Benjamin Jackson CFA
Stock Analyst at Jefferies
(3.54)
# 2,238
Out of 5,065 analysts
79
Total ratings
61.5%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Benjamin Jackson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: IPN Ipsen S.A. | Reiterated: Sell | €135.00 → €130.00 | €149.00 | -12.75% | 4 | Oct 8, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Buy | CHF 205.00 | CHF 176.05 | +16.44% | 35 | Sep 29, 2026 | |
| GMAB Genmab | Reiterated: Buy | n/a | $37.00 | - | 2 | Aug 7, 2026 | |
| SWX: CMHC Cosmo N.V. | Reiterated: Buy | CHF 140.00 → CHF 110.00 | CHF 51.90 | +111.95% | 3 | Jul 28, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 110.00 | CHF 124.70 | -11.79% | 5 | Feb 4, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €100.00 | €71.94 | +39.00% | 9 | Dec 29, 2025 | |
| SWX: ROP Roche Holding AG | Downgraded: Sell | CHF 270.00 → CHF 230.00 | CHF 379.20 | -39.35% | 6 | Oct 27, 2025 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,450p | 1,863p | n/a | 2 | Jul 30, 2025 | |
| LON: AZN AstraZeneca PLC | Reiterated: Hold | 10,900p | 12,446p | n/a | 2 | Jul 29, 2025 | |
| ETR: EVT Evotec SE | Reiterated: Hold | €6.80 | €2.57 | n/a | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.8 | $1.39 | n/a | 1 | Oct 7, 2024 |
Ipsen S.A.
Oct 8, 2026
Reiterated: Sell
Price Target: €135.00 → €130.00
Current: €149.00
Upside: -12.75%
Galderma Group AG
Sep 29, 2026
Reiterated: Buy
Price Target: CHF 205.00
Current: CHF 176.05
Upside: +16.44%
Genmab
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.00
Upside: -
Cosmo N.V.
Jul 28, 2026
Reiterated: Buy
Price Target: CHF 140.00 → CHF 110.00
Current: CHF 51.90
Upside: +111.95%
Novartis AG
Feb 4, 2026
Reiterated: Hold
Price Target: CHF 110.00
Current: CHF 124.70
Upside: -11.79%
Sanofi
Dec 29, 2025
Reiterated: Buy
Price Target: €100.00
Current: €71.94
Upside: +39.00%
Roche Holding AG
Oct 27, 2025
Downgraded: Sell
Price Target: CHF 270.00 → CHF 230.00
Current: CHF 379.20
Upside: -39.35%
GSK plc
Jul 30, 2025
Reiterated: Hold
Price Target: 1,450p
Current: 1,863p
Upside: n/a
AstraZeneca PLC
Jul 29, 2025
Reiterated: Hold
Price Target: 10,900p
Current: 12,446p
Upside: n/a
Evotec SE
Nov 13, 2024
Reiterated: Hold
Price Target: €6.80
Current: €2.57
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: $3.8
Current: $1.39
Upside: n/a